A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma.
Grace H HwangMaria F Pazyra-MurphyHyuk-Soo SeoSirano Dhe-PaganonSylwia A StopkaMarina DiPiazzaNizhoni SutterThomas W GeroAlison VolkertLincoln OmbeletsGeorgia A DittemoreMatthew G ReesMelissa A RonanJennifer A RothNathalie Y R AgarDavid A ScottRosalind A SegalPublished in: Cancer research (2024)
Development of a benzarone derivative that inhibits EYA1 and impedes the growth of SHH medulloblastoma provides an avenue for improving treatment of this malignant pediatric brain cancer.